Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shore

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
The Journal of Infectious Diseases|May 27, 2024
Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean CohortNell G Bond, Kayla R Shore, Emily J Engel, et al.
Nature Communications|May 25, 2017
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistancePaul M O'Neill, Richard K Amewu, Susan A Charman, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
The Journal of Infectious Diseases|May 27, 2024
Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean CohortNell G Bond, Kayla R Shore, Emily J Engel, et al.
Nature Communications|May 25, 2017
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistancePaul M O'Neill, Richard K Amewu, Susan A Charman, et al.
Pageof 6